Publications by authors named "Evangelos P Dimakakos"
Even today thromboangiitis obliterans has disease features that remain misunderstood or underappreciated. The epidemiology, etiology and pathophysiology of the disease are still unclear. Biomarkers and disease activity markers are lacking, thus clinical assessment is difficult.
View Article and Find Full Text PDFArticle Synopsis
- COVID-19 is caused by the SARS-CoV-2 virus, and there's growing concern about thrombotic events (blood clots) contributing to serious health issues in infected patients.
- The Global COVID-19 Thrombosis Collaborative Group discusses novel dosing strategies for common antithrombotic medications, particularly heparin, and explores the potential of other less common drugs for preventing COVID-19-related blood clots.
- The article emphasizes the need for further research, including clinical trials, to evaluate the safety and effectiveness of various treatments, and considers the role of immunomodulators with potential antithrombotic benefits.
Article Synopsis
- * Patients with existing thrombotic issues may face challenges when they contract COVID-19, affecting how their blood-thinning treatments are managed.
- * The authors discuss the importance of using technology to help treat not only COVID-19 patients but also those with thrombotic diseases during the pandemic.
Venous thromboembolism (VTE) is a typical complication in patients with lung cancer. Khorana score is an established tool for thromboembolic risk stratification of ambulatory patients with cancer undergoing outpatient chemotherapy. The aim of this study was to evaluate the predictive value of the Khorana score for VTE and death in patients with lung adenocarcinoma during first-line or adjuvant chemotherapy.
View Article and Find Full Text PDFCurrent guidelines recommend low-molecular-weight heparin treatment in patients with cancer with established venous thromboembolism (VTE). The aim of this article was to study the pharmacological properties and effectiveness of tinzaparin in patients with cancer as well as its potential anticancer properties. A search of PubMed and ScienceDirect databases up to March 2016 was carried out to identify published studies that detect the properties and use of tinzaparin in oncology.
View Article and Find Full Text PDFPurpose: Considering the high prevalence of lung cancer, our purpose was to summarize the existing literature to identify the several factors that contribute to the increased risk of venous thromboembolism (VTE) in patients with lung cancer and to analyze the current recommendations for thromboprophylaxis and treatment of VTE in those patients.
Methods: We searched the Medline and EMBASE databases from February 1985 to February 2014 to identify retrospective and prospective randomized controlled studies that investigate one or more risk factors for VTEs in patients with lung cancer.
Results: A VTE is a major complication for patients diagnosed with lung cancer.
Interdisciplinary lymphology: the best place for each discipline in a team.
Int J Low Extrem Wounds
March 2012
The term lymphology includes both the physiology and the pathology of the lymphatic system. Many disciplines are involved in the study of the lymphatic system, to correctly diagnose lymphatic diseases and to ultimate provide the best available treatment for the patient. Lymphedema is one of the most common lymphatic diseases, potentially causing significant problems for the patient and for the health system in general.
View Article and Find Full Text PDFThe aim of this work was to study the safety and effectiveness of silver foam dressing (Contreet® Ag, Coloplast, Humlebaek, Denmark) in promoting the healing of infected venous ulcers over 9 weeks of treatment. Forty-two patients with infected venous ulcers were included and randomized into two groups. Group A had 21 patients (12 women and 9 men, mean age 61.
View Article and Find Full Text PDF